FDA AI in Cardiology: Heart Monitoring Moves From the Clinic to the Body
Cardiology is becoming one of the clearest bridges between regulated medical AI, remote monitoring, ECG analysis, and consumer heart devices.
FDA AI in Radiology: Why Medical Imaging Became AI’s First Beachhead
Radiology dominates the FDA AI-enabled medical device list because medical imaging already turns the body into structured data, making it the first large proving ground for regulated medical AI.
FDA AI Medical Devices and the Quiet Reality of Medical AI
The FDA’s list of AI-enabled medical devices reveals a quieter medical AI revolution: narrow, regulated tools already helping clinicians see, measure, monitor, and act earlier.
Your Cells Have a Mechanical Age, and AI Can Now Read It to Predict Breast Cancer Risk
A UC Berkeley and City of Hope team published a landmark AI platform called MechanoAge in Lancet’s eBioMedicine that measures the physical stress-response of individual breast cells to identify cancer…
AI Is Now Building Drugs That Target Aging Itself: Inside the Longevity Board and the New Science of Healthspan Medicine
A Nobel laureate on its board. The world’s largest pharmaceutical company as a founding partner. And a scientific mission to build drugs that target aging itself. Inside Insilico Medicine’s Longevity…
The First Longevity Board: How Insilico Medicine Is Using AI to Target the Biology of Aging Itself
Insilico Medicine has formed the industry’s first Longevity Board, chaired by Eli Lilly’s Group VP of Molecular Discovery and featuring Nobel laureate Michael Levitt. Inside the AI strategy, dual-purpose targets,…
AI-Designed Drugs Are Entering Human Trials: Inside the Quiet Pharmaceutical Revolution of 2026
For the first time in pharmaceutical history, molecules designed almost entirely by artificial intelligence are surviving Phase 2 trials in real patients. From Insilico’s rentosertib to Isomorphic Labs’ multi-billion dollar…
The AI Stool Test That Could Replace Colonoscopy: Inside the Gut Microbiome Science Changing Cancer Screening
Researchers at the University of Geneva used machine learning to map gut bacteria at the subspecies level and detect 90% of colorectal cancers from a simple stool sample. The test…
The AI Drug Discovery Pipeline Reaches Its Moment of Truth in 2026
More than 173 AI-discovered drug programs are now in clinical development, with the first Phase III readouts arriving this year. From Insilico Medicine’s rentosertib to Generate Biomedicines’ AI-designed antibody for…
The AI Scientists Are Already Running the Lab: How Autonomous Multi-Agent Systems Are Reinventing Drug Discovery
A new generation of AI systems does not just assist scientists; it organizes itself into research teams, designs experiments, debates hypotheses, and identifies drug candidates at speeds no human laboratory…
